Hennessy Advisors Inc Regeneron Pharmaceuticals, Inc. Transaction History

Hennessy Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$705.89 - $766.39 $211,767 - $229,917	-300 Reduced 6.82%	4,100 $2.96 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $54,835 - $73,884	-100 Reduced 2.22%	4,400 $2.6 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $773,656 - $907,958	-1,300 Reduced 22.41%	4,500 $3.14 Million
Q4 2021 Jan 25, 2022	SELL	$543.48 - $670.97 $108,696 - $134,194	-200 Reduced 3.33%	5,800 $3.66 Million
Q3 2021 Oct 12, 2021	SELL	$574.03 - $680.96 $57,403 - $68,096	-100 Reduced 1.64%	6,000 $3.63 Million
Q2 2021 Jul 28, 2021	BUY	$472.8 - $558.54 $47,280 - $55,854	100 Added 1.67%	6,100 $3.41 Million
Q1 2021 Apr 19, 2021	BUY	$446.73 - $548.2 $2.68 Million - $3.29 Million	6,000 New	6,000 $2.84 Million
Q1 2018 May 02, 2018	SELL	$315.82 - $393.78 $634,798 - $791,497	-2,010 Closed	0 $0
Q4 2017 Jan 23, 2018	BUY	$358.63 - $469.95 $720,846 - $944,599	2,010	2,010 $756,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Hennessy Advisors Inc with notifications on news.